Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Transcenta was Selected to Present the Preclinical Data of TST004 at the 2022 ISN Frontiers Meetings of Complement Related Kidney Diseases 2022-06-28 08:00
BGI Group Continues To Lead In Life Sciences 22 Years After The Human Genome Project 2022-06-27 16:20
Abcam: Appointment of Vice President of Investor Relations 2022-06-27 14:00
Antengene Announces Clinical Trial Collaboration with BeiGene to Evaluate Selinexor in Combination with Tislelizumab in T and NK-Cell Lymphoma 2022-06-27 08:30
Congratulations to Dragon Boat Biopharmaceutical from Sanyou Biopharmaceuticals on the NMPA acceptance of the CLDN 18.2/CD47 bsAb clinical trial application 2022-06-26 08:00
Sanyou Biopharmaceuticals forged strategic partnership with Dragon Sail Pharmaceutical to upgrade integrated innovative antibody drug R&D 2022-06-25 08:00
Daewoong Pharmaceutical begins multinational phase 2 clinical trial for DWN12088, a new drug for idiopathic pulmonary fibrosis 2022-06-24 21:00
Novavax COVID-19 Vaccine Nuvaxovid™ Recommended for Expanded Conditional Marketing Authorization in the European Union by CHMP for Adolescents Aged 12 Through 17 2022-06-24 03:24
Use of BioMAP Platform to Assess Nutraceuticals Published in BioMed Central 2022-06-24 01:00
MGI Wins Company Innovation of the Year at 2022 Globee® Awards for Advanced COVID-19 Response Efforts 2022-06-24 00:17
Alterity Therapeutics Announces Regulatory Authorization to Proceed with ATH434 Phase 2 Clinical Trial in Italy 2022-06-23 23:00
Berry Oncology launches HIFI Pan-Cancer Screening, a multi-cancer early screening product for detecting six high-risk cancers at one time 2022-06-23 22:39
Viva Biotech Successfully Held The 3rd Annual Partnership Summit 2022-06-23 20:30
I-Mab Receives Top Rankings in Five Categories by Institutional Investor 2022-06-23 20:00
Hyundai Mobis plans to extend biotech to mobility to take care of the driver's health 2022-06-23 16:00
Mojia Biotech Completes Series B Financing to Advance Manufacturing of Bio-based Materials 2022-06-23 09:00
Sirnaomics to Present the Latest Developments of Dual-Targeted RNAi Therapeutics based on its Proprietary GalAhead™ Program at the 4th Annual RNA Therapeutic: From Concept to Clinic Symposium 2022-06-22 00:29
Scientists take the first step to master an all-powerful cell type in the beginning of life 2022-06-21 23:10
3Z closes $2 million funding for preclinical development of novel ADHD and Insomnia therapeutics identified by 3Z´s zebrafish drug discovery platform 2022-06-20 21:01
Acepodia Announces FDA Clearance of IND Application for ACE1831, an Anti-CD20 Armed Allogeneic gamma delta T-cell Therapy Candidate to Treat Patients with non-Hodgkin's Lymphoma 2022-06-20 20:00
1 168 169 170 171 172 452